1. "Meeting abstract"
  2. "2010"
Formats
  1. Meeting Abstract (717)
Groups
  1. Department of Medicine (308)
  2. Surgery (209)
  3. Solid Tumor Oncology Division (203)
  4. GSK Faculty (164)
  5. Survivorship Research (157)
  6. Center for Hematologic Malignancies (119)

More Groups

People
  1. Richard Barakat (35)
  2. Robert Soslow (33)
  3. Nadeem Abu-Rustum (31)
  4. Dennis Chi (28)
  5. Clifford Hudis (24)
  6. Laura Tang (24)

More People

Years
  1. 2010 (717)
Publications
  1. Journal of Clinical Oncology (205)
  2. Modern Pathology (64)
  3. Cancer Research (59)
  4. Blood (50)
  5. Laboratory Investigation (44)
  6. International Journal of Radiation Oncology, Biology, Physics (39)

More Publications

Publishers
  1. American Society of Clinical Oncology (205)
  2. Elsevier Inc. (109)
  3. Nature Research (64)
  4. American Association for Cancer Research (59)
  5. American Society of Hematology (50)
  6. Nature Publishing Group (46)

More Publishers

Results (717)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predicting chemotherapy toxicity in older adults with cancer: A prospective 500 patient multicenter study
    Meeting Abstract

    Hurria, A.; Togawa, K.; Mohile, S. G.; Owusu, C.; Klepin, H. D.; Gross, C.; Lichtman, S. M.; Katheria, V.; Klapper, S.; Tew, W. P.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Prostate cancer with disseminated intravascular coagulation and excessive fibrinolysis (DIC XFL)
    Meeting Abstract

    Hyman, D. M.; Scher, H. I.; Kampel, L. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Impact of miscoding dose-limiting toxicities in dose-escalation phase I studies
    Meeting Abstract

    Iasonos, A.; Zohar, S.; O'Quigley, J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Shah, M. A.; Kelsen, D. P.; Janjigian, Y. Y.; Tang, L. H.; Campbell, J.; Fuqua, L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Gene expression profiles to predict outcome following liver resection in patients with metastasis of colorectal cancer
    Meeting Abstract

    Ito, H.; Mo, Q.; Maker, A. V.; Li-Xuan, Q.; Allen, P.; De Matteo, R. P.; Fong, Y.; Blumgart, L. H.; Jarnagin, W. R.; D'Angelica, M. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Incidence and risk factors for biliary sclerosis following adjuvant hepatic arterial infusion with floxuridine after hepatectomy for metastatic colorectal cancer
    Meeting Abstract

    Ito, K.; Ito, H.; Kemeny, N. E.; Gonen, M.; Allen, P.; Fong, Y.; DeMatteo, R. P.; Blumgart, L. H.; Jarnagin, W. R.; D'Angelica, M. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The possibility of molecular targeted therapy in patients with pulmonary large cell neuroendocrine carcinoma
    Meeting Abstract

    Iyoda, A.; Travis, W. D.; Jiang, S. X.; Nezu, K.; Ogawa, F.; Amano, H.; Okayasu, I.; Rusch, V. W.; Yoshimura, H.; Satoh, Y.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer
    Meeting Abstract

    Hughes, K. S.; Schnaper, L. A.; Cirrincione, C.; Berry, D. A.; McCormick, B.; Muss, H. B.; Shank, B.; Hudis, C.; Winer, E. P.; Smith, B. L.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Re-induction with ipilimumab, gp100 peptide vaccine, or a combination of both from a phase III, randomized, double-blind, multicenter study of previously treated patients with unresectable stage III or IV melanoma
    Meeting Abstract

    Hodi, F. S.; O'Day, S.; McDermott, D. F.; Haanen, J. B.; Robert, C.; Zhu, X.; Yellin, M. J.; Ibrahim, R. A.; Hoos, A.; Wolchok, J. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Refinement of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) via cognitive interviewing
    Meeting Abstract

    Hay, J.; Atkinson, T. M.; Mendoza, T. R.; Reeve, B. B.; Willis, G.; Gagne, J. J.; Abernethy, A. P.; Cleeland, C. S.; Schrag, D.; Basch, E. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save